In an interview with OncLive in September, 2020, Dr. Treon from DFCI discussed the various BTK inhibitors that are now available or in trials.

BTK Inhibitors transform WM management

Along the same lines, a very valuable discussion was moderated by Dr. Treon, including experts from Europe and Australia.  This was recorded for the Oncology Learning Network in 2019.

It is available as both a video and as a transcript.

Video: BTK Inhibitors for the treatment of WM
Transcript: BTK Inhibitors for the treatment of WM